What to expect at MASS
MASS Is the Number-One Provider of Content, Innovation, and Practical Insights for Medical Affairs Professionals!
The Medical Affairs Strategic Summit is an educational platform that provides a holistic view of medical affairs, allowing organizations to develop a unified scientific voice that will help position teams as a strategic and credible customer-facing partner in the healthcare marketplace.
This event serves as an opportunity for biotech and big pharma leadership to share insights on how the various functions within a medical organization can collaborate more effectively and develop a medical strategy that aligns with business objectives while creating a unified scientific voice that serves the patient.
Who Attends
This conference attracts SVPs, VPs, Directors, Heads and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include:
|
Medical Affairs |
Medical Science Liaisons/Field Medical |
|
Medical/Operations |
KOL/Thought Leader Relations/Engagement |
|
Investigator-Initiated Research (IIR)/Research Collaborations |
Medical/Communications |
|
Medical Information |
Medical Education |
|
Publication Planning |
Health Economics and Outcomes Research/HEOR |
|
Compliance/Legal |
|
Past Participants of MASS Include
|
AbbVie |
Abiomed |
Adamas Pharmaceuticals |
|
Alcon |
Amgen |
Arbor Pharmaceuticals |
|
Astellas |
AveXis |
Boston Scientific |
|
Bristol-Meyers Squibb |
Eli Lily |
Emergent BioSolutions |
|
EXACT Sciences |
Galderma |
Genentech, Inc |
|
Gilead Science |
INVIVO Communications |
Kindred Biosciences, Inc. |
|
MEI Pharma |
Mitsubishi Tanabe Pharma America, Inc. |
Napo Pharmaceuticals |
|
Orchard Therapeutics |
Recordati Rare Diseases, Inc |
Sage Therapeutics |
|
Sanofi |
Spectranetics |
Stryker Neurovascular |
|
Takeda Pharmaceuticals |
Terumo BCT, Inc. |
TESARO, Inc. |
|
United Therapeutics |
Vertex Pharmaceuticals |
|